GSK-3β inhibitor 14

GSK-3β inhibitor 14

Cat. No.: DIA-0243106

Size: 10 mg Size: 25 mg Size: 50 mg Size: 100 mg Size: Customer Size
Product Information
CAS No. 863004-48-2
Formula C17H17NOS
Molecular Weight 283.39
SMILES O=C1CC(C)SC2=CC=CC=C2N1CC3=CC=CC=C3
Target GSK-3
Product Description GSK-3β inhibitor 14 (Compound 6i), benzothiazepinone derivative, is a weak GSK-3β inhibitor (IC50 >100 μM).
Format & Storage
Format Solid
Color White to off-white
Purity 99.92%
Shipping Room temperature in the continental U.S. Other areas may vary.
Storage In solvent: -80°C, 6 months; -20°C, 1 month (protect from light)
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
logo

Ace Therapeutics has a team of wellknown experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.

Quick Links
Contact Info
Copyright © Ace Therapeutics. All Rights Reserved.
Top